Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-01
DOI
10.3389/fphar.2021.785403
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPARγ
- (2021) Jiaqing Xiang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway
- (2020) Shu Yang et al. PHARMACOLOGICAL RESEARCH
- ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
- (2020) Elliott Lilley et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pterostilbene prevents hepatocyte EMT in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF-β1/Smads signaling
- (2019) Lin Song et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immunological abnormalities in patients with primary biliary cholangitis
- (2019) Wen-Tao Ma et al. CLINICAL SCIENCE
- Systemic inflammation and portal vein thrombosis in cirrhotic patients with gastroesophageal varices
- (2019) Xiaoquan Huang et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Effects of pterostilbene on diabetes, liver steatosis and serum lipids
- (2019) Saioa Gómez-Zorita et al. CURRENT MEDICINAL CHEMISTRY
- Primary biliary cholangitis: Old and novel therapy
- (2018) Annarosa Floreani et al. European Journal of Internal Medicine
- A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- (2018) Kris V. Kowdley et al. HEPATOLOGY
- Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis
- (2018) Karim C. El Kasmi et al. Nature Communications
- Fine-tuning of SIRT1 expression is essential to protect the liver from cholestatic liver disease
- (2018) Britt A Blokker et al. HEPATOLOGY
- Pterostilbene alleviates polymicrobial sepsis-induced liver injury: Possible role of SIRT1 signaling
- (2017) Xiaojing Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury
- (2017) Kojiro Nakamura et al. JOURNAL OF HEPATOLOGY
- Beneficial effect of resveratrol on α‑naphthyl isothiocyanate‑induced cholestasis via regulation of the FXR pathway
- (2017) Lili Ding et al. Molecular Medicine Reports
- Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis
- (2016) Supriya R. Kulkarni et al. HEPATOLOGY
- Role of farnesoid X receptor in cholestasis
- (2016) Zhi Qing Yuan et al. Journal of Digestive Diseases
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
- (2015) John C McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377
- (2015) Wei Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
- (2015) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- Fibrates and cholestasis
- (2015) Nisanne S. Ghonem et al. HEPATOLOGY
- Novel therapeutic targets in primary biliary cirrhosis
- (2015) Jessica K. Dyson et al. Nature Reviews Gastroenterology & Hepatology
- Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms
- (2014) Tao Wang et al. ACTA PHARMACOLOGICA SINICA
- Characterization of animal models for primary sclerosing cholangitis (PSC)
- (2014) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management
- (2013) John E. Eaton et al. GASTROENTEROLOGY
- SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling
- (2013) Juan L. García-Rodríguez et al. HEPATOLOGY
- Hepatic Deletion of SIRT1 Decreases Hepatocyte Nuclear Factor 1 /Farnesoid X Receptor Signaling and Induces Formation of Cholesterol Gallstones in Mice
- (2012) A. Purushotham et al. MOLECULAR AND CELLULAR BIOLOGY
- Sirtuins as regulators of metabolism and healthspan
- (2012) Riekelt H. Houtkooper et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches
- (2010) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- Pterostilbene Inhibits Colorectal Aberrant Crypt Foci (ACF) and Colon Carcinogenesis via Suppression of Multiple Signal Transduction Pathways in Azoxymethane-Treated Mice
- (2010) Yi-Siou Chiou et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation
- (2010) Dipanjan Chanda et al. NUCLEIC ACIDS RESEARCH
- FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
- (2009) Jongsook Kim Kemper et al. Cell Metabolism
- p53 Attenuates Lipopolysaccharide-Induced NF- B Activation and Acute Lung Injury
- (2009) G. Liu et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now